PUBLISHER: KBV Research | PRODUCT CODE: 1155527
PUBLISHER: KBV Research | PRODUCT CODE: 1155527
LAMEA Neurological Biomarkers Market Size, Share & Industry Trends Analysis Report By Type (Proteomic, Genomic, Metabolomic), By Application (Alzheimer's Disease, Parkinson's Disease and Multiple Sclerosis), By Country and Growth Forecast, 2022 - 2028
The Latin America, Middle East and Africa Neurological Biomarkers Market would witness market growth of 17.6% CAGR during the forecast period (2022-2028).
Innovative biomarkers, which are biological markers that objectively evaluate and quantify physiological or pathophysiological processes or pharmacological responses to treatment, have been proposed to assist in the assessment and treatment of patients with neurological abnormalities beyond the scope of currently accepted practice. Rapid scientific and technical progress has made it possible to accurately and economically measure novel biomarkers.
Evidence points to a potential range of clinical applications, including refining the decision criteria for early diagnosis and risk stratification, assisting in disease monitoring, and serving as submitters in experimental studies and clinical trials.
Additionally, biomarkers may accurately capture the various components of illness heterogeneity and etiology, assisting in patient characterization, guiding focused, customized treatments, and forecasting intervention response outcomes. However, even though many possible biomarkers have been put forth and thoroughly examined, relatively few of them are currently used in ordinary clinical practice, and the search for new markers for brain injury is still ongoing.
In South Africa, there were 3.171 million (5.4%) people who were 65 or older in 2019, and this number is expected to rise to 4.404 million (6.7%) by 2030, according to the World Population Ageing 2019. This is expected to raise the number of dementia patients over time, spark the attention of current players, and motivate them to boost their investments in the country. The use of neurological biomarkers treatment in this area has been accelerated by the rising number of neurological biomarkers market.
The Brazil market dominated the LAMEA Neurological Biomarkers Market by Country in 2021; thereby, achieving a market value of $220.2 Million by 2028. The Argentina market is poised to grow at a CAGR of 18.2% during (2022 - 2028). Additionally, The UAE market would exhibit a CAGR of 17.2% during (2022 - 2028).
Based on Type, the market is segmented into Proteomic, Genomic, Metabolomic and Others. Based on Application, the market is segmented into Alzheimer's Disease, Parkinson's Disease and Multiple Sclerosis. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include F. HOFFMANN-LA ROCHE LTD., Bio-Rad Laboratories, Inc., Merck Group, PERKINELMER INC., Shimadzu corporation, Thermo Fisher Scientific, Inc., Quanterix Corporation, Neuro-Bio Ltd., BioMerieux S.A. and Myriad Genetics, Inc.
Scope of the Study
Market Segments covered in the Report:
By Type
- Proteomic
- Genomic
- Metabolomic
- Others
By Application
- Alzheimer's Disease
- Parkinson's Disease
- Multiple Sclerosis
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Companies Profiled
- F. HOFFMANN-LA ROCHE LTD.
- Bio-Rad Laboratories, Inc.
- Merck Group
- PERKINELMER INC.
- Shimadzu corporation
- Thermo Fisher Scientific, Inc.
- Quanterix Corporation
- Neuro-Bio Ltd.
- BioMerieux S.A.
- Myriad Genetics, Inc.
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 LAMEA Neurological Biomarkers Market, by Type
- 1.4.2 LAMEA Neurological Biomarkers Market, by Application
- 1.4.3 LAMEA Neurological Biomarkers Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market Overview
- 2.1 Introduction
- 2.1.1 Overview
- 2.1.1.1 Market Composition & Scenarios
- 2.1.1 Overview
- 2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints
Chapter 3. LAMEA Neurological Biomarkers Market by Type
- 3.1 LAMEA Proteomic Market by Country
- 3.2 LAMEA Genomic Market by Country
- 3.3 LAMEA Metabolomic Market by Country
- 3.4 LAMEA Others Market by Country
Chapter 4. LAMEA Neurological Biomarkers Market by Application
- 4.1 LAMEA Alzheimer's Disease Market by Country
- 4.2 LAMEA Parkinson's Disease Market by Country
- 4.3 LAMEA Multiple Sclerosis Market by Country
Chapter 5. LAMEA Neurological Biomarkers Market by Country
- 5.1 Brazil Neurological Biomarkers Market
- 5.1.1 Brazil Neurological Biomarkers Market by Type
- 5.1.2 Brazil Neurological Biomarkers Market by Application
- 5.2 Argentina Neurological Biomarkers Market
- 5.2.1 Argentina Neurological Biomarkers Market by Type
- 5.2.2 Argentina Neurological Biomarkers Market by Application
- 5.3 UAE Neurological Biomarkers Market
- 5.3.1 UAE Neurological Biomarkers Market by Type
- 5.3.2 UAE Neurological Biomarkers Market by Application
- 5.4 Saudi Arabia Neurological Biomarkers Market
- 5.4.1 Saudi Arabia Neurological Biomarkers Market by Type
- 5.4.2 Saudi Arabia Neurological Biomarkers Market by Application
- 5.5 South Africa Neurological Biomarkers Market
- 5.5.1 South Africa Neurological Biomarkers Market by Type
- 5.5.2 South Africa Neurological Biomarkers Market by Application
- 5.6 Nigeria Neurological Biomarkers Market
- 5.6.1 Nigeria Neurological Biomarkers Market by Type
- 5.6.2 Nigeria Neurological Biomarkers Market by Application
- 5.7 Rest of LAMEA Neurological Biomarkers Market
- 5.7.1 Rest of LAMEA Neurological Biomarkers Market by Type
- 5.7.2 Rest of LAMEA Neurological Biomarkers Market by Application
Chapter 6. Company Profiles
- 6.1 F. Hoffmann-La Roche Ltd.
- 6.1.1 Company Overview
- 6.1.2 Financial Analysis
- 6.1.3 Segmental and Regional Analysis
- 6.1.4 Research & Development Expense
- 6.2 Bio-Rad laboratories, Inc.
- 6.2.1 Company Overview
- 6.2.2 Financial Analysis
- 6.2.3 Segmental and Regional Analysis
- 6.2.4 Research & Development Expenses
- 6.3 Merck Group
- 6.3.1 Company Overview
- 6.3.2 Financial Analysis
- 6.3.3 Segmental and Regional Analysis
- 6.3.4 Research & Development Expense
- 6.3.5 Recent strategies and developments:
- 6.3.5.1 Partnerships, Collaborations, and Agreements:
- 6.4 PerkinElmer, Inc.
- 6.4.1 Company Overview
- 6.4.1 Financial Analysis
- 6.4.2 Segmental and Regional Analysis
- 6.4.3 Research & Development Expense
- 6.5 Shimadzu Corporation
- 6.5.1 Company Overview
- 6.5.2 Financial Analysis
- 6.5.3 Segmental and Regional Analysis
- 6.6 Thermo Fisher Scientific, Inc.
- 6.6.1 Company Overview
- 6.6.2 Financial Analysis
- 6.6.3 Segmental and Regional Analysis
- 6.6.4 Research & Development Expense
- 6.7 BioMerieux S.A.
- 6.7.1 Company Overview
- 6.7.2 Financial Analysis
- 6.7.3 Segmental and Regional Analysis
- 6.7.4 Research & Development Expenses
- 6.8 Myriad Genetics, Inc.
- 6.8.1 Company Overview
- 6.8.2 Financial Analysis
- 6.8.3 Segmental Analysis
- 6.8.4 Research & Development Expenses
- 6.9 Quanterix Corporation
- 6.9.1 Company Overview
- 6.9.2 Financial Analysis
- 6.9.3 Segmental and Regional Analysis
- 6.9.4 Research & Development Expenses
- 6.9.5 Recent strategies and developments:
- 6.9.5.1 Partnerships, Collaborations, and Agreements:
- 6.10. Neuro-Bio Ltd.
- 6.10.1 Company Overview
LIST OF TABLES
- TABLE 1 LAMEA Neurological Biomarkers Market, 2018 - 2021, USD Million
- TABLE 2 LAMEA Neurological Biomarkers Market, 2022 - 2028, USD Million
- TABLE 3 LAMEA Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
- TABLE 4 LAMEA Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
- TABLE 5 LAMEA Proteomic Market by Country, 2018 - 2021, USD Million
- TABLE 6 LAMEA Proteomic Market by Country, 2022 - 2028, USD Million
- TABLE 7 LAMEA Genomic Market by Country, 2018 - 2021, USD Million
- TABLE 8 LAMEA Genomic Market by Country, 2022 - 2028, USD Million
- TABLE 9 LAMEA Metabolomic Market by Country, 2018 - 2021, USD Million
- TABLE 10 LAMEA Metabolomic Market by Country, 2022 - 2028, USD Million
- TABLE 11 LAMEA Others Market by Country, 2018 - 2021, USD Million
- TABLE 12 LAMEA Others Market by Country, 2022 - 2028, USD Million
- TABLE 13 LAMEA Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
- TABLE 14 LAMEA Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
- TABLE 15 LAMEA Alzheimer's Disease Market by Country, 2018 - 2021, USD Million
- TABLE 16 LAMEA Alzheimer's Disease Market by Country, 2022 - 2028, USD Million
- TABLE 17 LAMEA Parkinson's Disease Market by Country, 2018 - 2021, USD Million
- TABLE 18 LAMEA Parkinson's Disease Market by Country, 2022 - 2028, USD Million
- TABLE 19 LAMEA Multiple Sclerosis Market by Country, 2018 - 2021, USD Million
- TABLE 20 LAMEA Multiple Sclerosis Market by Country, 2022 - 2028, USD Million
- TABLE 21 LAMEA Neurological Biomarkers Market by Country, 2018 - 2021, USD Million
- TABLE 22 LAMEA Neurological Biomarkers Market by Country, 2022 - 2028, USD Million
- TABLE 23 Brazil Neurological Biomarkers Market, 2018 - 2021, USD Million
- TABLE 24 Brazil Neurological Biomarkers Market, 2022 - 2028, USD Million
- TABLE 25 Brazil Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
- TABLE 26 Brazil Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
- TABLE 27 Brazil Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
- TABLE 28 Brazil Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
- TABLE 29 Argentina Neurological Biomarkers Market, 2018 - 2021, USD Million
- TABLE 30 Argentina Neurological Biomarkers Market, 2022 - 2028, USD Million
- TABLE 31 Argentina Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
- TABLE 32 Argentina Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
- TABLE 33 Argentina Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
- TABLE 34 Argentina Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
- TABLE 35 UAE Neurological Biomarkers Market, 2018 - 2021, USD Million
- TABLE 36 UAE Neurological Biomarkers Market, 2022 - 2028, USD Million
- TABLE 37 UAE Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
- TABLE 38 UAE Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
- TABLE 39 UAE Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
- TABLE 40 UAE Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
- TABLE 41 Saudi Arabia Neurological Biomarkers Market, 2018 - 2021, USD Million
- TABLE 42 Saudi Arabia Neurological Biomarkers Market, 2022 - 2028, USD Million
- TABLE 43 Saudi Arabia Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
- TABLE 44 Saudi Arabia Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
- TABLE 45 Saudi Arabia Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
- TABLE 46 Saudi Arabia Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
- TABLE 47 South Africa Neurological Biomarkers Market, 2018 - 2021, USD Million
- TABLE 48 South Africa Neurological Biomarkers Market, 2022 - 2028, USD Million
- TABLE 49 South Africa Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
- TABLE 50 South Africa Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
- TABLE 51 South Africa Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
- TABLE 52 South Africa Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
- TABLE 53 Nigeria Neurological Biomarkers Market, 2018 - 2021, USD Million
- TABLE 54 Nigeria Neurological Biomarkers Market, 2022 - 2028, USD Million
- TABLE 55 Nigeria Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
- TABLE 56 Nigeria Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
- TABLE 57 Nigeria Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
- TABLE 58 Nigeria Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
- TABLE 59 Rest of LAMEA Neurological Biomarkers Market, 2018 - 2021, USD Million
- TABLE 60 Rest of LAMEA Neurological Biomarkers Market, 2022 - 2028, USD Million
- TABLE 61 Rest of LAMEA Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
- TABLE 62 Rest of LAMEA Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
- TABLE 63 Rest of LAMEA Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
- TABLE 64 Rest of LAMEA Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
- TABLE 65 KEY INFORMATION - F. Hoffmann-La Roche Ltd.
- TABLE 66 Key Information - Bio-Rad Laboratories, Inc.
- TABLE 67 key Information - Merck GrouP
- TABLE 68 key Information - PerkinElmer, Inc.
- TABLE 69 Key Information - Shimadzu Corporation
- TABLE 70 Key Information - Thermo Fisher Scientific, Inc.
- TABLE 71 Key information - BioMerieux S.A.
- TABLE 72 Key Information - Myriad Genetics, Inc.
- TABLE 73 Key Information - QUANTERIX CORPORATION
- TABLE 74 Key Information - Neuro-Bio Ltd.
List of Figures
- FIG 1 Methodology for the research
